Bexorg's machine, BrainEx, is used to restore molecular and cellular activity in dead human brain, housed in a black bucket. (Credit: Ryan Cross for Endpoints News)

June 10, 2025 10:00 AM EDT

In Focus

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work

Ryan Cross

Senior Science Correspondent

NEW HAVEN, CT — In an old brick building across the street from Yale School of Medicine, a jumble of plastic tubes rhythmically pulse and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work

Ryan Cross

Senior Science Correspondent

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Have sky-high sales projections set the obesity market up to fail?

Vaxart shares surge on norovirus vaccine data as it seeks funding for new trials

Updated: Novo makes another cardiometabolic deal focused on oral medicines

Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March

Cabaletta Bio shares CAR-T results in three autoimmune conditions

McKesson leads the charge in revolutionizing precision oncology in community practices

Ex­clu­sive: Re­boot­ing dead hu­man brains, a biotech start­up seeks to rein­vent ear­ly drug test­ing work

Senior Science Correspondent

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work